Australia en camino de alcanzar los objetivos de eliminación del VHC de la OMS tras la rápida adopción inicial del tratamiento con AAD: un estudio de modelo
Summary Subsidized direct-acting antiviral (DAA) treatment recently became available to all adults living with chronic hepatitis C (HCV) in Australia. Based on rapid uptake (32,600 people initiated DAA in 2016) we estimated the impact on HCV epidemiology and mortality in Australia and determined if Australia can meet the WHO HCV elimination targets by 2030. Using […]